GH1, growth hormone 1, 2688

N. diseases: 686; N. variants: 27
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0242292
Disease: McCune-Albright Syndrome
McCune-Albright Syndrome
0.090 Biomarker disease BEFREE We evaluated hypothalamic-pituitary-adrenal function in two cases of typical MAS associated with fibrous dysplasia and growth hormone excess. 31801917 2020
CUI: C0242292
Disease: McCune-Albright Syndrome
McCune-Albright Syndrome
0.090 Biomarker disease BEFREE Our results suggest that long-term untreated growth hormone excess in patients with MAS-related craniofacial fibrous dysplasia might end compromising cerebrospinal fluid flow. 29984378 2018
CUI: C0242292
Disease: McCune-Albright Syndrome
McCune-Albright Syndrome
0.090 Biomarker disease BEFREE Hyperfunction endocrinopathies including hyperthyroidism, growth hormone excess and cortisol excess are typical presentations in MAS. 30150346 2018
CUI: C0242292
Disease: McCune-Albright Syndrome
McCune-Albright Syndrome
0.090 Biomarker disease BEFREE Growth hormone-Insulin-like growth factor 1 axis hyperactivity on bone fibrous dysplasia in McCune-Albright Syndrome. 29672904 2018
CUI: C0242292
Disease: McCune-Albright Syndrome
McCune-Albright Syndrome
0.090 Biomarker disease BEFREE This study aims to describe the clinical manifestations of GH excess in the context of MAS and analyze the responses of these patients to treatments. 28007843 2017
CUI: C0242292
Disease: McCune-Albright Syndrome
McCune-Albright Syndrome
0.090 Biomarker disease BEFREE We conclude that the development of cardiac myxomas in CNC may be associated with increased GH secretion, in a manner analogous to the association between fibrous dysplasia and GH excess in McCune-Albright syndrome, a condition similar to CNC. 27535175 2016
CUI: C0242292
Disease: McCune-Albright Syndrome
McCune-Albright Syndrome
0.090 GeneticVariation disease BEFREE McCune-Albright syndrome (MAS) typically comprises the constellation of polyostotic fibrous dysplasia, café-au-lait spots, and associated endocrinopathies including gonadotropin-independent precocious puberty, excessive growth hormone production and gigantism, hyperthyroidism, and hyperparathyroidism. 20197676 2010
CUI: C0242292
Disease: McCune-Albright Syndrome
McCune-Albright Syndrome
0.090 Biomarker disease BEFREE Pegvisomant for the treatment of gsp-mediated growth hormone excess in patients with McCune-Albright syndrome. 16720661 2006
CUI: C0242292
Disease: McCune-Albright Syndrome
McCune-Albright Syndrome
0.090 Biomarker disease BEFREE McCune-Albright syndrome (MAS) is characterized by polyostotic fibrous dysplasia, café-au-lait lesions, and a variety of endocrine disorders, including precocious puberty, hyperthyroidism, hypercortisolism, growth hormone excess, and hyperprolactinemia. 1594625 1992